Success Stories: NIW Status Confirmed without RFE for a Pediatric Resident in Immunology from D.C., Credit to Our Team of Experts
Client’s Testimonial:
“Thank you so much! I really appreciate all your help!”
On April 22nd, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Pediatric Resident in the Field of Immunology (Approval Notice).
General Field: Immunology
Position at the Time of Case Filing: Pediatric Resident
Country of Origin: Bosnia and Herzegovina
State of Residence at the Time of Filing: District of Columbia
Approval Notice Date: April 22nd, 2022
Processing Time: 19 months, 21 days
Case Summary:
The I-140 EB2-NIW or National Interest Waiver is one of the many visa types designed for individuals whose work is of national interest to the United States. Thus when an M.D. in Immunology came to our firm for her NIW filing, we made sure to aid her case the best we could. This meant a thorough search of her academic and professional documents for use in her petition. This yielded the following data:
- We gave a detailed description of her proposed endeavor and showed that she is an expert in the field of immunology, and her proposed endeavor is to work on utilizing immunological and molecular biology techniques to develop inclusive and effective T-cell therapies.
- She wants to improve the outcomes of patients suffering from high-risk solid tumor cancer, hematologic malignancies, and post-transplant viral infections.
- We said that her research advancing her proposed endeavor is of great importance because it supports the creation of comprehensive and effective treatments for viral and cancer patients who have exhibited poor responses to conventional therapeutics, including chemotherapy, surgery, and radiation.
- Therefore, her research efforts are extremely valuable for patients who are suffering from severe cases of either solid tumor or hematologic cancer as well as associated viral complications. We said that her work to treat viral complications from hematopoietic stem cell transplantations (HSCTs) also holds particular salience for the United States.
- Finally, her research has also been financially supported by numerous government institutions that specialize in medical research such as the National Cancer Institute, the National Heart, Lung, and Blood Institute, and the National Center for Advancing Translational Studies.
- Furthermore, her work has been an integral facet of six different clinical trials, and she has also shared her research methodologies and techniques through a provisional patent application.
- Her research has also resulted in 2 peer-reviewed journal articles and 9 peer-reviewed abstracts (3 first-authored).
- Her publications have also been cited a total of 260 times according to Google Scholar, showing the worth of her work for her peers.
- Finally, she had also received letters from 4 experts who supported her claim to the category by saying that her work was of great significance for the United States.